Patent ID: 11931381
Assignee: YAMAGUCHI UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 16:
17. The composition of claim 14, wherein the expression vector is any of the following (a) to (e): (a) an expression vector containing a nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, a nucleic acid encoding IL-7, and a nucleic acid encoding CCL19; (b) the following two expression vectors (b-1) and (b-2): (b-1) an expression vector containing a nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen; and (b-2) an expression vector containing a nucleic acid encoding IL-7 and a nucleic acid encoding CCL19; (c) the following two expression vectors (c-1) and (c-2): (c-1) an expression vector containing a nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, and a nucleic acid encoding IL-7; and (c-2) an expression vector containing a nucleic acid encoding CCL19; (d) the following two expression vectors (d-1) and (d-2): (d-1) an expression vector containing a nucleic acid encoding IL-7; and (d-2) an expression vector containing a nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, and a nucleic acid encoding CCL19; and (e) the following three expression vectors (e-1), (e-2) and (e-3): (e-1) an expression vector containing a nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen; (e-2) an expression vector containing a nucleic acid encoding IL-7; and (e-3) an expression vector containing a nucleic acid encoding CCL19.